资讯
New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...
(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果